← Back to Analyst Consensus 
KALV Hold
KalVista Pharmaceuticals, Inc.
Current Price —
Implied Upside —
Analysts 13
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| May 1, 2026 | HC Wainwright & Co. | downgrade | Buy → Neutral | — | 44% |
| Apr 30, 2026 | Needham | downgrade | Buy → Hold | — | 50% |
| Mar 26, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Mar 26, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 46% |
| Mar 25, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Jan 9, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $37 | 44% |
| Jan 9, 2026 | Needham | maintain | Buy → Buy | $35 | 50% |
| Jan 6, 2026 | Needham | maintain | Buy → Buy | $32 | 50% |
| Dec 4, 2025 | Needham | reiterate | Buy → Buy | $28 | 50% |
| Nov 11, 2025 | Citizens | maintain | Market Outperform → Market Outperform | $28 | 46% |
| Sep 12, 2025 | Needham | reiterate | Buy → Buy | $28 | 50% |
| Sep 12, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $28 | 53% |
| Jul 11, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $27 | 44% |
| Jul 8, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $27 | 53% |
| Jul 8, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $27 | 44% |
| Jul 7, 2025 | Leerink Partners | maintain | Outperform → Outperform | $20 | 51% |
| Apr 8, 2025 | Needham | reiterate | Buy → Buy | $28 | 50% |
| Mar 26, 2025 | Needham | reiterate | Buy → Buy | $28 | 50% |
| Mar 26, 2025 | Citizens Capital Markets | reiterate | Market Outperform → Market Outperform | $19 | 49% |
| Mar 26, 2025 | Jones Trading | maintain | Buy → Buy | $30 | 50% |
| Mar 14, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Mar 13, 2025 | Needham | reiterate | Buy → Buy | $28 | 50% |
| Mar 3, 2025 | Citizens Capital Markets | reiterate | Market Outperform → Market Outperform | $19 | 49% |
| Jan 31, 2025 | JMP Securities | initiate | — → Market Outperform | $19 | 53% |
| Jan 7, 2025 | TD Cowen | initiate | — → Buy | $30 | 54% |
| Dec 18, 2024 | B of A Securities | initiate | — → Buy | $22 | 53% |
| Dec 9, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $0 | 50% |
| Dec 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Dec 5, 2024 | Needham | reiterate | Buy → Buy | $28 | 50% |
| Oct 7, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Sep 27, 2024 | Jones Trading | initiate | — → Buy | $35 | 50% |
| Sep 9, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Sep 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Sep 6, 2024 | Needham | reiterate | Buy → Buy | $32 | 50% |
| Jul 15, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Jul 12, 2024 | Needham | maintain | Buy → Buy | $32 | 50% |
| Jun 18, 2024 | Needham | reiterate | Buy → Buy | $35 | 50% |
| May 3, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $20 | 44% |
| May 1, 2024 | Needham | reiterate | Buy → Buy | $35 | 50% |
| Apr 11, 2024 | Needham | reiterate | Buy → Buy | $35 | 50% |
| Mar 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $24 | 44% |
| Mar 11, 2024 | Needham | maintain | Buy → Buy | $35 | 50% |
| Feb 14, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $24 | 44% |
| Feb 13, 2024 | Needham | maintain | Buy → Buy | $35 | 50% |
| Sep 8, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Aug 22, 2023 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $20 | 50% |
| Jul 10, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Apr 21, 2023 | Needham | reiterate | — → Buy | $22 | 50% |
| Mar 10, 2023 | Cantor Fitzgerald | maintain | Overweight → Overweight | $33 | 50% |
| Mar 10, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $16 | 44% |
Price Target Trend
Apr 20, 2026 Oct 25, 2026
EPS Estimates
0q —
+1q —
+1y —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days